Terms: = Skin cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
171 results:
1. Pholiotic acid promotes apoptosis in human metastatic melanoma cells.
Avola R; Graziano ACE; Madrid A; Clericuzio M; Cardile V; Russo A
Chem Biol Interact; 2024 Feb; 390():110894. PubMed ID: 38301881
[TBL] [Abstract] [Full Text] [Related]
2. Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2022.
Morton CA; Szeimies RM; Braathen LR
Eur J Dermatol; 2023 Oct; 33(5):467-473. PubMed ID: 38297922
[TBL] [Abstract] [Full Text] [Related]
3. Thiol starvation triggers melanoma state switching in an ATF4 and NRF2-dependent manner.
Meinert M; Jessen C; Hufnagel A; Kreß JKC; Burnworth M; Däubler T; Gallasch T; Xavier da Silva TN; Dos Santos AF; Ade CP; Schmitz W; Kneitz S; Friedmann Angeli JP; Meierjohann S
Redox Biol; 2024 Apr; 70():103011. PubMed ID: 38219574
[TBL] [Abstract] [Full Text] [Related]
4. pten-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells.
Wang S; Riedstra CP; Zhang Y; Anandh S; Dudley AC
Br J Cancer; 2024 Mar; 130(4):555-567. PubMed ID: 38148377
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.
Olatunji G; Aderinto N; Adefusi T; Kokori E; Akinmoju O; Yusuf I; Olusakin T; Muzammil MA
Medicine (Baltimore); 2023 Dec; 102(48):e36421. PubMed ID: 38050252
[TBL] [Abstract] [Full Text] [Related]
6. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
[TBL] [Abstract] [Full Text] [Related]
7. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
8. Comparative analysis of the effect of hypoxia in two different tumor cell models shows the differential involvement of pten control of proangiogenic pathways.
Majewska A; Brodaczewska K; Filipiak-Duliban A; Kieda C
Biochem Cell Biol; 2024 Feb; 102(1):47-59. PubMed ID: 37459649
[TBL] [Abstract] [Full Text] [Related]
9. Trametinib in Patients With
Wisinski KB; Flamand Y; Wilson MA; Luke JJ; Tawbi HA; Hong F; Mitchell EP; Zwiebel JA; Chen H; Gray RJ; Li S; McShane LM; Rubinstein LV; Patton D; Williams PM; Hamilton SR; Behrens RJ; Pennington KP; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2023 Apr; 7():e2200421. PubMed ID: 37053535
[TBL] [Abstract] [Full Text] [Related]
10. The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.
Lim SY; Shklovskaya E; Lee JH; Pedersen B; Stewart A; Ming Z; Irvine M; Shivalingam B; Saw RPM; Menzies AM; Carlino MS; Scolyer RA; Long GV; Rizos H
Nat Commun; 2023 Mar; 14(1):1516. PubMed ID: 36934113
[TBL] [Abstract] [Full Text] [Related]
11. Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I; Pastorino L; Tanda ET; Andreotti V; Dalmasso B; Solari N; Mascherini M; Cabiddu F; Guadagno A; Coco S; Allavena E; Bruno W; Pietra G; Croce M; Gangemi R; Piana M; Zoppoli G; Ferrando L; Spagnolo F; Queirolo P; Ghiorzo P
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901733
[TBL] [Abstract] [Full Text] [Related]
12. Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Frias A; Di Leo L; Antoranz A; Nazerai L; Carretta M; Bodemeyer V; Pagliuca C; Dahl C; Claps G; Mandelli GE; Andhari MD; Pacheco MP; Sauter T; Robert C; Guldberg P; Madsen DH; Cecconi F; Bosisio FM; De Zio D
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868570
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract] [Full Text] [Related]
14. In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma.
Jan Z; Aqeel M; Munir A; Saeed A; Sadia H; Kalsoom S; Nadeem T; Bashir Z; Awan L; Ud Din S; Muhammad Ali G
Pak J Pharm Sci; 2022 May; 35(3):731-739. PubMed ID: 35791470
[TBL] [Abstract] [Full Text] [Related]
15. Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation.
Huang RSP; Tse JY; Harries L; Graf RP; Lin DI; Murugesan K; Hiemenz MC; Parimi V; Janovitz T; Decker B; Severson E; Levy MA; Ramkissoon SH; Elvin JA; Ross JS; Williams EA
Oncologist; 2022 Aug; 27(8):655-662. PubMed ID: 35552752
[TBL] [Abstract] [Full Text] [Related]
16. Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions.
Massimino M; Stella S; Micale G; Motta L; Pavone G; Broggi G; Piombino E; Magro G; Soto Parra HJ; Manzella L; Vigneri P
Cancer Genomics Proteomics; 2022; 19(3):350-361. PubMed ID: 35430568
[TBL] [Abstract] [Full Text] [Related]
17. An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
Vranic S; Gatalica Z
Clin Breast Cancer; 2022 Jun; 22(4):e576-e585. PubMed ID: 35027319
[TBL] [Abstract] [Full Text] [Related]
18. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of pten expression and AKT/PI3K signaling by a demethylating agent.
Ko H; Ahn HJ; Kim YI
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114
[TBL] [Abstract] [Full Text] [Related]
19. Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in
White MG; Szczepaniak Sloane R; Witt RG; Reuben A; Gaudreau PO; Andrews MC; Feng N; Johnson S; Class CA; Bristow C; Wani K; Hudgens C; Nezi L; Manzo T; De Macedo MP; Hu J; Davis R; Jiang H; Prieto P; Burton E; Hwu P; Tawbi H; Gershenwald J; Lazar AJ; Tetzlaff MT; Overwijk W; Woodman SE; Cooper ZA; Marszalek JR; Davies MA; Heffernan TP; Wargo JA
Oncoimmunology; 2021; 10(1):1992880. PubMed ID: 34777916
[TBL] [Abstract] [Full Text] [Related]
20. The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance.
Parkman GL; Foth M; Kircher DA; Holmen SL; McMahon M
Exp Dermatol; 2022 Jan; 31(1):43-56. PubMed ID: 34717019
[TBL] [Abstract] [Full Text] [Related]
[Next]